<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-70-SS-bTECKAA</udiDi>
    <basicUdiDi>B-70-SS-bTECKAA</basicUdiDi>
    <tradeName>TLA GUT (UC)</tradeName>
    <deviceName>TLA GUT</deviceName>
    <manufacturerName>TLA Targeted Immunotherapies AB</manufacturerName>
    <manufacturerSrn>SE-MF-000039975</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>B030299</emdnCode>
    <emdnDescription>APHERESIS THERAPY DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00170-SS-bTECK</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-17T01:28:22.541Z</lastUpdated>
  </row>
</eudamedExport>